Telomir Pharmaceuticals, Inc. (NASDAQ:TELO), a clinical-stage biotechnology company developing small

MIAMI, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Telomir Pharmaceuticals, Inc. (NASDAQ: TELO), a clinical-st

In matched Cleveland Clinic and Jewish General Hospital samples, blood-based TELO enumeration detect

Gainers DataMEDS AI (NASDAQ:MEDS) shares increased by 12.9% to $4.24 during Friday's after-mark

Gainers Alaunos Therapeutics (NASDAQ:TCRT) shares moved upwards by 30.0% to $2.08 during Thursday&#

Maxim Group analyst Jason McCarthy initiates coverage on Telomir Pharmaceuticals (NASDAQ:TELO) wi

MIAMI, Sept. 17, 2026 (GLOBE NEWSWIRE) -- Telomir Pharmaceuticals, Inc. (NASDAQ: TELO), a clinical-s

Telomir Pharmaceuticals, Inc. (NASDAQ:TELO), a clinical-stage biotechnology company developing small

MIAMI, Sept. 14, 2026 (GLOBE NEWSWIRE) -- Telomir Pharmaceuticals, Inc. (NASDAQ:TELO), a clinical-st

Shares of Telomir Pharmaceuticals, Inc. (NASDAQ: TELO - Get Free Report) were down 3.4% during mid-d

Gainers Bluejay Diagnostics (NASDAQ:BJDX) stock moved upwards by 42.0% to $1.42 during Tuesday'

Gainers China Pharma Holding (AMEX:CPHI) shares increased by 713.2% to $7.4 during Tuesday's re

Gainers iTonic Holdings (NASDAQ:ITOC) stock increased by 8.1% to $0.3 during Friday's after-mar

Insulin Resistance Was Normalized Following 14 Days of Treatment, Supporting Restoration of Glucose

Study Published in Advances in Redox Research Demonstrated Dose-Dependent Survival Improvement, Redu

Company Plans to Initiate First-in-Human Phase 1/2 Trial in 1H 2026, Anchored by a Leading U.S. Acad

Telomir Pharmaceuticals, Inc. (NASDAQ: TELO - Get Free Report) shares traded up 1.4% during trading

Transaction establishes global ownership rights of lead program and includes initial capital funding

Telomir Pharmaceuticals (NASDAQ: TELO - Get Free Report) and Jaguar Animal Health (NASDAQ: JAGX - Ge

First-in-class metal-modulating epigenetic therapy targeting iron-dependent pathways with preclinica

Iron-rescue experiments confirm tumor cell mortality is mechanistically driven, not nonspecific cyto

Cellular findings show Telomir-Zn modulates intracellular metal balance linked to oxidative stress,

Telomir Pharmaceuticals (NASDAQ: TELO - Get Free Report) is expected to be issuing its results befor

electroCore (NASDAQ: ECOR - Get Free Report) and Telomir Pharmaceuticals (NASDAQ: TELO - Get Free Re

In a TNBC animal model with limited responsiveness to chemotherapy, Telomir-1 demonstrated statistic

Telomir Pharmaceuticals, Inc. (NASDAQ: TELO - Get Free Report) was down 8.9% on Monday. The stock tr

No treatment-related adverse toxicity was observed across completed GLP studies, with consistent sys

TMQ: 230% | Shares of mining companies that operate in Alaska are trading higher after President Tru